Pre-Market Movers

StockRadar.ru

Gapping down

In reaction to disappointing earnings/guidance:

DXTR -23.4%,KONA -20.9%,RELY -17.6%,BIOC -16.1%,SSKN -14.9%,RHE -12.5%,LPTH -11.8%,CLRB -11.6%,PBYI -11.2%,WAC -10.8%,TTD -10.2%,ESL -9.4%,RDFN -8.6%,QTM -8.2%,TPC -7.3%,AIRG -6.1%,CLIR -5.7%,AVGR -4.8%,XIN -3.6%, FH-3.3%, XON-3%, XELA-3%, ACRX-2.6%, BPTH-2.1%, ESNC-2%, CRMD-1.9%, JWN-1.6%, ONVO-1.3%, FSIC-1.3%, KDMN-1.1%, IPWR-1%, EFX -1%

Other news:

NVCN -14.4% (prices offering of 6,609,588 Series A units of Neovasc and 19,066,780 Series B units of the Co, at a price of $1.46 per Unit)
INFI -13.6% (reports clinical and translational data for IPI-549; well tolerated and demonstrated clinical activity)
ATTO -7% (prices secondary offering by selling shareholder of 12,295,082 ordinary shares at $9.00 per share)
HRTX -3.7% (announces FDA approval of CINVANTI injectable emulsion, for intravenous infusion)
ARLZ -1% (files for $100 mln mixed securities shelf offering)

Analyst comments:

Gapping up

In reaction to strong earnings/guidance:

BLFS +17.5%,OMER+14.6%, HTZ+12.9%, AYTU+12.7%, RGSE+12.2%, ZSAN+11.4%, ATEC+10.3%, VJET+10.1%,IMMU +9.9%, (also Board of Directors has voted to appoint Michael Pehl as President and Chief Executive Officer, effective December 7),WTT +9.9%,GROW +9.8%,TRXC +9%,CATB +8.5%,ESEA +7.8%,SGYP +7.1%,AVID +6.4%,ANY +6%,SNOA +5.5%, (also files for $75 mln mixed securities shelf offering),SNOA +5.5%,TRTC +5%,CTSO +4.8%,NVDA +4.6%,MT +4.6%,JYNT +4.4%,CDXC +4.3%,DDS +4.2%,AYX +4.2%,SPRT +4%,CLMT +3.6%,NAO +3.6%,XXII +2.9%,NH +2.9%,ENDP +2.5%,ZOES +2.4%,ARGS +2.4%,APVO +2%, (also enters into Equity Distribution Agreement under which it may issue and sell through Piper Jaffray shares of common stock having an aggregate offering price of up to $17.5 mln ) APVO+2%, RIBT+1.9%, BDSI+1.8%, JAGX+1.7%, TRIL+1.7%, PULM+1.3%, UEPS+1.2%, LOMA+1.1%, KLDX+1%, VUZI+0.9%, NWSA+0.8%, DIS+0.8%

M&A news:

EA +0.8% (Electronic Arts to acquire Respawn Entertainment for $151 mln in cash and up to $164 mln in the form of restricted stock units; expected to be neutral to EA's net income in 2018 and 2019)

Other news:

DVAX +15.5% (announces the FDA has approved HEPLISAV-B for prevention of Hepatitis B in adults)
ATOS +5.3% (Iroquois Capital Management discloses 9.01% passive stake)
THS +4.4% (will webcast Investor Day presentation on Monday November 13 - will discuss the the strategy, operations and TreeHouse 2020 initiatives)
CAR +4.1% (following HTZ results)
MDR +1.8% ( announces a 'major' contract award from a Middle East customer)
AMD +1.5% (following NVDA results)
WDC +1.2% (announced an authorization to resume potential repurchases of its common stock under a previously approved $5 bln repurchase program by its board)
PANW +1% (rebounding after closing 9+ pts lower)

Analyst comments:

VKTX +2.3% (resumed with a Buy at H.C. Wainwright; tgt $7 (stock closed at 2.19 on Thur))
AAN +1.4% (upgraded to Strong Buy from Mkt Perform at Raymond James)
UBS +1.2% (upgraded to Buy from Neutral at BofA/Merrill)
CVS +1.2% (upgraded to Buy at Needham)

Report Page